Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials
OPEN American journal of kidney diseases : the official journal of the National Kidney Foundation | 25 Feb 2017
SC Palmer, DJ Tunnicliffe, D Singh-Grewal, D Mavridis, M Tonelli, DW Johnson, JC Craig, A Tong and GF Strippoli
Intravenous (IV) cyclophosphamide has been first-line treatment for inducing disease remission in lupus nephritis. The comparative efficacy and toxicity of newer agents such as mycophenolate mofetil (MMF) and calcineurin inhibitors are uncertain.
* Data courtesy of Altmetric.com